Safety and Effectiveness of TEVAR in Native Proximal Landing Zone 2 for Chronic Type B Aortic Dissection in Patients With Genetic Aortic Syndrome

Abstract

Objectives

The aim of this study is to report the safety and effectiveness of thoracic endovascular aortic repair (TEVAR) in a native proximal landing zone (PLZ) 2 for chronic type B aortic dissection (TBAD) patients with genetic aortic syndrome (GAS).

Methods

A retrospective review of a single center database to identify patients with GAS treated with TEVAR in native PLZ 2 for chronic TBAD and thoracic false lumen aneurysm between February 2012 and February 2018 was undertaken.

Results

In total, 31 patients with GAS (24 Marfan syndrome [MFS], 5 Loeys-Dietz syndrome [LDS], and 2 vascular Ehlers-Danlos syndrome [vEDS]) were treated by endovascular repair. Nineteen patients were treated by TEVAR as index procedures with 8 patients (5 females, mean age = 55, range = 36–79 years old) receiving TEVAR in native PLZ 2. Left subclavian artery (LSA) perfusion was preserved in all 8 patients: by left common carotid artery-LSA bypass in 6 patients, chimney stenting of the LSA in 1 patient, and partial coverage of LSA ostium in 1 patient. Technical success was achieved in all patients (100%). There was no 30 day mortality (0%). The 30 day morbidity (0%) was free from major complications. The median follow-up was 40 months (range = 7–79). One patient died due to non-aortic-related cause. Native PLZ 2 was free from complications in MFS patients (5/8). Two patients with LDS developed type Ia endoleak with aneurysmal progression. One patient was treated by proximal extension with a double inner branched arch stent-graft landing in the replaced ascending aorta. The other one was treated with frozen elephant trunk.

Conclusion

Thoracic endovascular aortic repair in native PLZ 2 was safe and effective with no early or midterm PLZ complications in patients with MFS with chronic TBAD in this limited series. Native PLZ 2 is not safe in patients with LDS and should only be used in emergencies as a bridging to open repair.

Keywords

aortic dissection Ehlers-Danlos syndrome Loeys-Dietz syndrome landing zone Marfan syndrome endovascular repair

Get full access to this article

View all access options for this article.

References

Riambau

Böckler

Brunkwall

, et al. Editor’s choice—management of descending thoracic aorta diseases: clinical practice guidelines of the European Society for Vascular Surgery (ESVS). Eur J Vasc Endovasc Surg. 2017;53(1):4–52.

Lombardi

Hughes

Appoo

, et al. Society for Vascular Surgery (SVS) and Society of Thoracic Surgeons (STS) reporting standards for type B aortic dissections. J Vasc Surg. 2020;71:723.

Spanos

Nana

Behrendt

, et al. Management of descending thoracic aortic diseases: similarities and differences among cardiovascular guidelines. J Endovasc Ther. 2021;28(2):323–331.

Czerny

Schmidli

Adler

, et al; EACTS/ESVS Scientific Document Group. Current options and recommendations for the treatment of thoracic aortic pathologies involving the aortic arch: an expert consensus document of the European Association for Cardio-Thoracic surgery (EACTS) and the European Society for Vascular Surgery (ESVS). Eur J Vasc Endovasc Surg. 2019;55:133–162.

Pellenc

Girault

Roussel

, et al. Optimising aortic endovascular repair in patients with Marfan syndrome. Eur J Vasc Endovasc Surg. 2020;59(4):577–585.

Waterman

Feezor

Lee

, et al. Endovascular treatment of acute and chronic aortic pathology in patients with Marfan syndrome. J Vasc Surg. 2012;55(5):1234–1240; discussion 1240–1241.

Qato

Conway

, et al. Outcomes of thoracic endovascular aneurysm repair (TEVAR) in patients with connective tissue disorders. Vasc Endovascular Surg. 2020;54(8):676–680.

Shalhub

Eagle

Asch

, et al; GenTAC Investigators for the Genetically Triggered Thoracic Aortic Aneurysms and Cardiovascular Conditions (GenTAC) Consortium. Endovascular thoracic aortic repair in confirmed or suspected genetically triggered thoracic aortic dissection. J Vasc Surg. 2018;68(2):364–371.

Faure

El Batti

Abou Rjeili

, et al. Stent-assisted, balloon-induced intimal disruption and relamination of aortic dissection in patients with Marfan syndrome: midterm outcomes and aortic remodeling. J Thorac Cardiovasc Surg. 2018;156(5):1787–1793.

10.

Eid-Lidt

Gaspar

Meléndez-Ramírez

, et al. Endovascular treatment of type B dissection in patients with Marfan syndrome: mid-term outcomes and aortic remodeling. Catheter Cardiovasc Interv. 2013;82:E898–E905.

11.

Nordon

Hinchliffe

Holt

, et al. Endovascular management of chronic aortic dissection in patients with Marfan syndrome. J Vasc Surg. 2009;50(5):987–991.

12.

Geisbüsch

Kotelis

von Tengg-Kobligk

, et al. Thoracic aortic endografting in patients with connective tissue diseases. J Endovasc Ther. 2008;15:144–149.

13.

Marcheix

Rousseau

Bongard

, et al. Stent grafting of dissected descending aorta in patients with Marfan’s syndrome: mid-term results. JACC Cardiovasc Interv. 2008;1:673–680.

14.

Botta

Russo

La Palombara

, et al. Stent graft repair of descending aortic dissection in patients with Marfan syndrome: an effective alternative to open reoperation? J Thorac Cardiovasc Surg. 2009;138(5):1108–1114.

15.

Alsac

Khantalin

Julia

, et al. The significance of endoleaks in thoracic endovascular aneurysm repair. Ann Vasc Surg. 2011;25(3):345–351.

16.

Miura

Kurimoto

Maruyama

, et al. Thoracic endovascular aortic repair on zone 2 landing for type B aortic dissection. Ann Vasc Surg. 2019;60:120–127.

17.

Mesar

Alie-Cusson

Rathore

, et al. Zone 3 versus zone 2 thoracic endovascular aortic repair for acute type B aortic dissection: the case for a more proximal landing zone. J Vasc Surg. 2020;71(1):e19–e20.

18.

Kölbel

Diener

Larena-Avellaneda

, et al. Advanced endovascular techniques for thoracic and abdominal aortic dissections. J Cardiovasc Surg. 2013;54(1)(suppl 1):81–90.

19.

von Kodolitsch

De Backer

Schüler

, et al. Perspectives on the revised Ghent criteria for the diagnosis of Marfan syndrome. Appl Clin Genet. 2015;8:137–155.

20.

Byers

Belmont

Black

, et al. Diagnosis, natural history, and management in vascular Ehlers-Danlos syndrome. Am J Med Genet C Semin Med Genet. 2017;175(1):40–47.

21.

Loeys

Schwarze

Holm

, et al. Aneurysm syndromes caused by mutations in the TGF-beta receptor. N Engl J Med. 2006;355(8):788–798.

22.

Rohlffs

Tsilimparis

Diener

, et al. Chronic type B aortic dissection: indications and strategies for treatment. J Cardiovasc Surg. 2015;56(2):231–238.

23.

Mitchell

Ishimaru

Ehrlich

, et al. First International Summit on Thoracic Aortic Endografting: roundtable on thoracic aortic dissection as an indication for endografting. J Endovasc Ther. 2002;9(suppl 2):II98–II105.

24.

Eleshra

Kölbel

Tsilimparis

, et al. Candy-plug generation II for false lumen occlusion in chronic aortic dissection: feasibility and early results. J Endovasc Ther. 2019;26(6):782–786.

25.

Tsilimparis

Debus

Biehl

, et al. Fenestrated-branched endografts and visceral debranching plus stenting (hybrid) for complex aortic aneurysm repair. J Vasc Surg. 2018;67(6):1684–1689.